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Opposing roles of sB and sB-controlled SpoVG
in the global regulation of esxA in
Staphylococcus aureus
Bettina Schulthess1*, Dominik A Bloes1,2 and Brigitte Berger-Bächi1
Abstract
Background: The production of virulence factors in Staphylococcus aureus is tightly controlled by a complex web
of interacting regulators. EsxA is one of the virulence factors that are excreted by the specialized, type VII-like Ess
secretion system of S. aureus. The esxA gene is part of the sB-dependent SpoVG subregulon. However, the mode
of action of SpoVG and its impact on other global regulators acting on esxA transcription is as yet unknown.
Results: We demonstrate that the transcription of esxA is controlled by a regulatory cascade involving downstream
sB-dependent regulatory elements, including the staphylococcal accessory regulator SarA, the ArlRS two-
component system and SpoVG. The esxA gene, preceding the ess gene cluster, was shown to form a
monocistronic transcript that is driven by a sA promoter, whereas a putative sB promoter identified upstream of
the sA promoter was shown to be inactive. Transcription of esxA was strongly upregulated upon either sarA or sigB
inactivation, but decreased in agr, arlR and spoVG single mutants, suggesting that agr, ArlR and SpoVG are able to
increase esxA transcription and relieve the repressing effect of the sB-controlled SarA on esxA.
Conclusion: SpoVG is a sB-dependent element that fine-tunes the expression of esxA by counteracting the sB-
induced repressing activity of the transcriptional regulator SarA and activates esxA transcription.
Background
The production of virulence factors in Staphylococcus
aureus is coordinated by a network of two-component
systems, global regulators and transcription factors,
allowing optimal adaptation of the pathogen to a chan-
ging environment and stress conditions encountered
during the various stages of infection. A central regula-
tory element of virulence factor production in S. aureus
is the accessory gene regulator agr, a two-component
quorum sensor regulating gene expression in a growth-
dependent manner. The main effector molecule of the
agr operon is the regulatory RNAIII [1], which is
responsible essentially for the upregulation of secreted
proteins in the post-exponential phase. RNAIII tran-
scription is enhanced by the staphylococcal accessory
regulator SarA [2] and reduced by the alternative sigma
factor sB in strain Newman [3,4]. SarA is a winged helix
transcription factor influencing many virulence genes
[5,6]. The transcription of sarA in turn is directly acti-
vated by the alternative sigma factor sB [3], which con-
trols over 250 genes including virulence factors and
secondary regulators in a direct or indirect way [7].
Indirectly sB-controlled genes lack a sB consensus pro-
moter sequence, and are thought to be controlled by
secondary, sB-dependent regulatory elements. The yabJ-
spoVG operon, with SpoVG as effector molecule, is
besides SarA one of the directly sB -dependent second-
ary regulators [8]. SpoVG contributes to methicillin and
glycopeptide resistance, stimulates capsule synthesis, and
was recently shown to regulate a small sB-subregulon
comprising mainly excreted virulence factors including
the highly upregulated virulence factor EsxA [8-10].
Secretion of virulence factors is facilitated by several
translocation systems in S. aureus [11], the major Sec
pathway, the accessory Sec2 system [12], the twin-argi-
nine translocation pathway [13], and the type VII-like
specialized ESX secretion pathway (Ess) [14]. The Ess
system comprises a cluster of at least nine genes: esxAB,
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essABC, esaABC and esaD [14,15] and secretes proteins
with a size of approximately 100 amino acids containing
a helical structure and a conserved Trp-Xaa-Gly (WXG)
motif [16]. Three proteins were so far shown to be
exported by the staphylococcal Ess system, two
WXG100 family proteins, EsxA and EsxB, and the non-
WXG100 substrate EsaC [14,17]. All three proteins act
as pathogenicity factors in a murine model of staphylo-
coccal blood-borne dissemination and abscess formation
[14,17]. The actual role of EsxA, EsxB and EsaC remains
unclear. Structural analysis of EsxA suggests a role as
transport module or chaperone to assist export of pro-
teins by the Ess secretion pathway rather than being an
effector protein itself [18]. The esxA gene seems to be
under complex control. Besides being upregulated by
SpoVG [10], esxA was found to be upregulated by ArlR
[19]. The two-component system ArlRS [19,20] itself is
activated in an indirect way by sB in strain Newman
[3,9], adding a further level of complexity in the regula-
tion of esxA.
This study analyses the transcriptional control of esxA
by sB and the sB-dependent regulatory elements SarA,
ArlR, RNAIII and SpoVG.
Materials and methods
Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids are listed in Table 1.
Bacteria were grown on Luria Bertani (LB) agar (Becton
Dickinson, Franklin Lakes, NJ, USA) or in LB broth
with shaking (180 rpm) at 37°C in a flask to medium
ratio 5:1. Where required, media were supplemented
with 100 μg ml-1 ampicillin, 20 μg ml-1 chlorampheni-
col, 10 μg ml-1 erythromycin, or 10 μg ml-1 tetracycline.
Molecular biological methods
General molecular biology techniques were performed
according to standard protocols [32,33]. Sequencing was
done using the Big Dye Terminator Cycle Sequencing
Ready Reaction Kit and an ABI Prism 310 genetic analy-
zer (Applied Biosystems, Foster City, CA, USA).
Sequences were analyzed with the Lasergene software
package (DNASTAR, Inc., Madison, WI, USA).
Construction of ΔesxA mutants
The markerless deletion of esxA (nwmn_0219) in strains
Newman, BB1002 and NM143 was constructed using
the counter selection system of pKOR1 as described by
Bae et al. [28], using primer pairs oBS43/oBS44 and
oBS45/oBS46 (Table 2) to amplify sequences framing
esxA. Correct deletion of esxA in BS304, BS307 and
BS308, respectively, was confirmed by sequencing and
Southern blot analysis, and the absence of major rear-
rangements by pulsed-field gel electrophoresis [34].
Construction of BS309 and BS310
The Newman sarA mutant BS309 and the Newman agr
mutant BS310 were constructed by transducing the
ermB-tagged sarA mutation of NM520 [38], and the
ermB-tagged agr mutation of NM521 [38] respectively,
into Newman and selecting for erythromycin resistance.
Correct inactivation of the genes was confirmed by
sequencing and Southern blot analysis.
Plasmid construction
For the construction of promoter-lacZ reporter fusions,
DNA fragments covering the yabJ or esxA promoter of
strain Newman were amplified using primer pairs yab-
prom-bam-f/yab-prom-xho-r and Pnwmn0219F/
Pnwmn0219R-xho (Table 2), respectively. The PCR pro-
ducts were digested with BamHI and XhoI and ligated
into promoter probe plasmid pSB40N [29] upstream of
the lacZa reporter gene to obtain pyabJp and pesxAp.
For the construction of pesxAp-luc+ , the esxA promo-
ter region of strain Newman was amplified by PCR
using primer pair Pnwmn0219F-hind/Pnwmn0219R
(Table 1). The resulting PCR product was HindIII/NcoI-
digested and cloned into pSP-luc+ upstream of the luci-
ferase reporter gene luc+ . The esxA promoter-luc+
fusion of the resulting plasmid was amplified using the
primers Pnwnm0219F-hind/pSP-Luc XhoI, digested with
HindIII and XhoI and cloned into the E. coli-S. aureus
shuttle plasmid pBus1 to obtain plasmid pesxA-luc+ .
Plasmids pesxApΔsA-luc+ and pesxApΔsB-luc+ were
made by deleting the sA and sB promoter sequences,
respectively, from pesxAp-luc+ . The corresponding
DNA fragments were amplified with primer pairs
oBS49/oBS53 and oBS51/oBS54 (Table 2) from pesxAp-
luc+ and religated.
All plasmids constructs were confirmed by sequence
analyses.
Northern blot analysis
Overnight cultures were diluted 1:100 into LB, grown for
2 h, and then used to inoculate 100 ml of pre-warmed
LB to an optical density of 600 nm [OD600 nm] of 0.05.
Cell samples were taken at the time points indicated, cen-
trifuged at 12,000 × g and 4°C for 2 min, the pellets were
snap-frozen in liquid nitrogen. Total RNA was isolated
according to Cheung et al. [39]. RNA samples (8 μg)
were separated in a 1.5% agarose gel containing 20 mM
guanidine thiocyanate in 1 × Tris-borate-EDTA buffer
[40]. RNA transfer and detection were performed as pre-
viously described [41,42]. Digoxigenin (DIG) labelled
probes were amplified using the PCR DIG Probe synth-
esis kit (Roche, Basel, Switzerland). The primer pairs
used for amplification of the esxA, spoVG, asp23, arlR,
sarA and RNAIII probes are listed in Table 2.
Schulthess et al. BMC Microbiology 2012, 12:17
http://www.biomedcentral.com/1471-2180/12/17
Page 2 of 11
Primer extension
RNA was extracted from LR15 cultures that were grown to
OD600 nm 2.0, as described by Cheung et al. [39]. Primer
extension reactions were performed using 20 μg of total
RNA and 3 pmol of the 5’-biotin-labelled primers
pe_esxA_1 and pe_esxA_2 (Table 2) using Superscript II
reverse transcriptase (Invitrogen, Carlsbad, CA, USA),
according to the manufacturers instructions. Sequencing
reactions were performed using the Thermo Sequenase
Cycle Sequencing Kit (USB Corporation, Cleveland,
OH, USA) and template DNA amplified with primers
Pnmmn0219F and esxA_term-r from Newman genomic
DNA. The Biotin Chromogenic Detection Kit (Fermentas,
Burlington, Ontario, Canada) was used for biotin detection.
Table 1 Strains and plasmids used in this study
Strain or
plasmid
Relevant genotype; phenotype Reference or
source
S. aureus
Newman Clinical isolate, ATCC 25904, natural saeS constitutive mutant [21,22]
BS304 Newman ΔesxA, markerless deletion This study
SM148 Newman Δ(yabJ-spoVG)::erm(B); Emr [8]
IK184 Newman Δ(rsbUVW-sigB)::erm(B); Emr [23]
MS64 Newman sigB1(Am); Tcr [24]
SM99 Newman ΔarlR::cat; Cmr [9]
BS310 Newman Δagr::ermB; Emr This study
KS186 Newman Δagr::tet(M); Tcr [25]
BS309 Newman ΔsarA::ermB; Emr This study
LR15 Newman ΔsarA::tet(L); Tcr L. Reutimann
BB1002 Newman mec, MRSA derivative, Mcr [26]
BS307 BB1002 ΔesxA, markerless deletion This study
NM143 Newman GISA derivative, in vitro selected mutant; Ter [27]
BS308 NM143 ΔesxA, markerless deletion This study
E. coli
DH5a F-F80d/acZΔM15 recA1 Invitrogen
Plasmids
pKOR1 E. coli-S. aureus shuttle vector for markerless deletions using the counter selection system [28]
pAC7 Expression plasmid containing the PBAD promoter and the araC gene; Cm
r [29]
pAC7-sigB pAC7 with a 0.75 kb fragment containing the gene sigB from S. aureus Col; Cmr [30]
pBus1 E. coli-S. aureus shuttle plasmid with multicloning site from pBluescript II SK (Stratagene) and the rrnT14
terminator sequence from pLL2443; Tcr
[31]
pyabJ pBus1 containing a bacA promoter-yabJ ORF fusion construct; Tcr [10]
pspoVG pBus1 containing a bacA promoter-spoVG ORF fusion construct; Tcr [10]
pyabJspoVG pBus1 containing a bacA promoter-yabJ-spoVG operon fusion construct; Tcr [10]
pSP-luc+ Firefly luciferase casette vector; Apr Promega
pesxAp-luc+ pBus1 containing an esxAp-luc+ fusion fragment; Tcr This study
pesxApΔsA-luc
+
pesxAp-luc+ with deletion of the sA promoter This study
pesxApΔsB-luc
+
pesxAp-luc+ with deletion of the sB promoter This study
pSB40N Promoter probe plasmid; Apr [29]
pasp23p pSB40N with a 0.6 kb fragment covering the asp23 promoter region fused to the reporter gene lacZa; Apr [30]
pesxAp pSB40N with a 0.5 kb fragment covering the esxA promoter region fused to the reporter gene lacZa; Apr This study
pyabJp pSB40N with a 0.4 kb fragment covering the yabJ promoter region fused to the reporter gene lacZa; Apr This study
pSTM07 pSB40N with a 0.37 kb fragment covering the capA promoter region fused to the reporter gene lacZa; Apr [9]
a Abbreviations are as follows: Apr, ampicillin resistant; Cmr, chloramphenicol resistant; Emr, erythromycin resistant; Mcr, methicillin resistant; Tcr, tetracycline
resistant; Ter, teicoplanin resistant.
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Two-plasmid testing
Testing of the interaction of S. aureus promoters with E.
coli RNA polymerase containing S. aureus sB was done
essentially as described earlier [30]. The promoter-reporter
plasmids pasp23p (asp23 promoter); pyabJp (yabJ promo-
ter); pesxap (esxA promoter); and pSTM07 (capA promo-
ter); or the empty plasmid pSB40N, were transformed into
E. coli DH5a containing either pAC7-sigB or pAC7. The
color production of the clones was analyzed on LBACX-
ARA plates (LB agar containing 5 mg ml-1 lactose; 100 μg
ml-1 ampicillin; 40 μg ml-1 chloramphenicol; 20 μg ml-1 X-
Gal (5-bromo-4-chloro3-indolyl-D-galactopyranoside) and
2 μg ml-1 arabinose) [29].
Luciferase assay
Luciferase activity was measured as described earlier [3]
using the luciferase assay substrate and a Turner
Designs TD-20/20 luminometer (Promega).
Table 2 Oligonucleotide primers used in this study
Primer name Sequence (5’-3’)a reference
esxA deletion
oBS43 GGGGACAAGTTTTGTACAAAAAAGCAGGCTacgtttatcaaagacatacc This study
oBS44 gggggtaccaactagaaacctcctgaata This study
oBS45 gggggtaccgcattctgaaattggcaaag This study
oBS46 GGGGACCACTTTGTACAAGAAAGCTGGGTttatccatcgctgtattgtg This study
DIG probes
Nwmn0219-DIG-f tccagaggaaatcagagcaaa [10]
Nwmn0219-DIG-r cttgttcttgaacggcatca [10]
oSTM29 (spoVGf) gcgtcgacttattgcaaatgtattacatcgc [9]
oSTM43 (spoVGr) gcggagctccactcgtttccattacattagatg [8]
SasarAf agggaggttttaaacatggc [35]
SasarAf ctcgactcaataatgattcg [35]
RNAIII+ gtgatggaaaatagttgatgag [3]
RNAIII- gtgaatttgttcactgtgtcg [3]
arlRSprobe+ tcgtatcacatacccaacgc [36]
arlRSprobe- gagtatgatggacaagacgg [36]
SAasp23+ atgactgtagataacaataaagc [37]
SAasp23- ttgtaaaccttgtctttcttgg [37]
plasmid construction
Pnwmn0219F tgcggatccgatcacgttgatttgcgtgt This study
Pnwmn0219R-xho tgcctcgagctagaaacctcctgaatattttaag This study
yab-prom-bam-f gcgggatcctgctaatattttaaatttacc This study
yab-prom-xho-r gcgctcgagtactaaaactccttttatgaaaac This study
Pnwmn0219F-hind tgcaagcttgatcacgttgatttgcgtgt This study
Pnwmn0219R tgcccatggctagaaacctcctgaatattttaag This study
pSP-Luc XhoI accggcctcgagatcgatgatatcgaa This study
oBS49 tagttttttaagtatttttagtttttttta This study
oBS51 attcaatatatttatttaaaaaaaactaaaaa This study
oBS53 aggtaccttgagtaaggagcactttttcaa This study
oBS54 aggtaccattcatttttgtaatataaatgtgtatac This study
primer extension This study
pe_esxA_1 BIOTIN-ccataactagaaacctcctg This study
pe_esxA_2 BIOTIN-tgatttcctctggactcatc This study
esxA_term-r tgcggtaccatgcttatttcctttcagttg This study
a Restriction sites are underlined. Capital letters show the att sites.
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Protease activity
The proteolytic activity of S. aureus strains was deter-
mined on skim milk (Becton Dickinson, 75 g l-1) agar
plates as clear zones surrounding colonies.
Hemolytic activity
To compare the hemolytic activity, S. aureus strains
were grown on sheep blood agar and the clear halos
around the colonies were analyzed.
Susceptibility testing
Plates containing an antibiotic gradient were prepared
and inoculated by swabbing a 0.5 McFarland cell sus-
pension in physiological NaCl solution along the gradi-
ent as described before [27]. Growth was read after 24 h
and 48 h of incubation at 35°C. Teicoplanin and oxacil-
lin minimal inhibitory concentrations (MICs) were
determined using Etests according to the manufacturer’s
instructions (AB-Biodisk, Solna, Sweden).
Results and discussion
Transcriptional analysis of esxA
The 294 bp esxA gene (nwmn_0219, GenBank accession
no. NC_009641), coding for a small secreted protein
involved in staphylococcal virulence, is the first of at
least nine genes of the ess gene cluster encoding the
type VII-like ESX-1 secretion pathway (Ess) in S. aureus
(Figure 1A) [14,15]. Although esxA seems to belong
transcriptionally to the ess gene cluster [43], transcrip-
tional profiling produced one single esxA-specific tran-
script with a size of about 0.45 kb appearing in early
growth phase after 1 h and increasing slightly within
time (Figure 1B). No esxA-specific signals were detected
in the corresponding ΔesxA mutant BS304, confirming
the esxA deletion. The deletion of esxA had no polar
effects on the expression of the downstream ess genes,
nor on the divergently transcribed gene directly
upstream of esxA, predicted to be involved in staphylox-
anthin synthesis [37,44,45] (data not shown). Our results
aaggagcactttttcaaaaaatagtgtccctaaaaagttttgataaacttaaaatattcaggaggtttctagttatg
esxA
0 2.5 5.0 7.5 10.0 12.5
[kb]
16S
1 3 5 8
Newman
1 3 5 8
'esxA
[h]
B
A
C
C
T
RT
G
A
15.0
PVA
TSP RBS START
0.45 kb
Figure 1 esxA in S. aureus. A. Schematic representation of the ess locus of S. aureus Newman (GenBank accession no. NC_009641). ORF
notations correspond to those used by Anderson et al. [15]. The sA promoter, transcriptional start point (TSP) and ribosomal binding site (RBS)
as well as the start codon of esxA are indicated. B. Northern blot of esxA of strain Newman and the isogenic ΔesxA mutant (BS304) during
growth. The ethidium bromide-stained 16S rRNA pattern is shown as an indication of RNA loading. C. Primer extension analysis of esxA. Lanes C,
T, A and G show the dideoxy-terminator sequencing ladder and lane RT the reverse transcription product obtained using primer pe_esxA_2. The
TSP is marked by an arrow. The same TSP was identified using primer pe_esxA_1 (data not shown).
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suggest that esxA is located on a monocistronic tran-
script and is not co-transcribed with the remaining
genes of the ess gene cluster.
esxA promoter and terminator sequence analysis
In a microarray of strain Newman, esxA transcription was
found to be upregulated by the sB-controlled yabJ-spoVG
operon [10]. Searching the nucleotide sequence upstream
of the esxA ORF for potential sA (TTGACA-16/18-
TATAAT) [46,47] and sB (GTTTAA-12/15-GGGTAT)
[30] consensus promoter sequences and for a ribosomal
binding site (AGGAGG) [48], we identified 80 bp
upstream of esxA a putative sA promoter (TatACA-17-
TATtAT), and 155 bp upstream of esxA a potential sB
promoter (GgTTAA-12-GGGTAT). A proposed riboso-
mal binding site (RBS, AGGAGG) was located 9 bp
upstream of the esxA start codon (Figure 1A). Fourteen bp
downstream of the esxA stop codon we identified a puta-
tive Rho independent terminator consisting of a 13 bp
inverted repeat with a minimal free energy ΔG of -17 kcal/
mol as calculated by mfold [49].
Primer extension analysis located the transcriptional
start point (TSP) of esxA 74 bp upstream of the start
codon of esxA (Figure 1A-C). It was preceded by the
predicted -10 and -35 sA promoter elements, and
further up by the sB promoter.
To verify and compare the function of the putative sA
and sB promoter sequences, we cloned the esxA promo-
ter region upstream of the firefly luciferase reporter
gene and analyzed the luciferase activity of this con-
struct, pesxAp-luc+, as well as of constructs containing
either a deletion of the sA or sB promoter (pesxApΔsA-
luc+, pesxApΔsB-luc+). Whereas the relative luciferase
activities of pesxAp-luc+ and pesxApΔsB-luc+ after 3 h
of growth were comparable, pesxApΔsA-luc+ showed
almost no activity, suggesting that esxA possesses a sA-
dependent promoter (Figure 2). We could rule out a
direct involvement of sB in the control of the esxA pro-
moter, furthermore, by testing the esxA upstream region
in the heterologous two-plasmid system that was estab-
lished to identify sB-dependent S. aureus promoters
[30]. The upstream region of esxA was cloned into the
reporter plasmid pSB40N resulting in plasmid pesxAp
which then was introduced into E. coli DH5a containing
either pAC7-sigB, expressing the S. aureus sigB gene
from an inducible promoter, or the empty plasmid
pAC7. If the S. aureus sB - E. coli RNA polymerase core
enzyme hybrid recognized the esxA promoter, dark blue
colonies would be expected on the indicator LBACX-
ARA agar [29] in combination with pAC7-sigB, as with
the sB-dependent promoters of asp23 or yabJ (positive
controls); if not, uncolored colonies would be expected,
as with the sB-independent promoter of capA or the
empty pSB40N (negative controls). In contrast,
transformants containing the empty pAC7 vector should
produce uncolored colonies. However, both combina-
tions, pesxAp with either pAC7 or pAC7-sigB, developed
an identical only light blue color in E. coli DH5a, indi-
cating that the esxA promoter was recognized weakly by
an E. coli RNA polymerase, but that the observed tran-
scriptional activity was independent from sB (data not
shown). Overall, the results of the esxA promoter and
terminator sequence analyses supported a monocistronic
transcription of esxA from a sA-dependent promoter.
Effect of sB and sB-controlled SpoVG on esxA expression
To differentiate between the effect of sB and of the sB-
controlled yabJ-spoVG on the transcriptional control of
esxA, we followed the luciferase activity of the esxA pro-
moter-reporter fusion in pesxAp-luc+ during the growth
cycle in parental strain Newman, the corresponding
ΔrsbUVW-sigB mutant (IK184), and in the ΔyabJ-spoVG
mutant (SM148). The luciferase activity increased in the
parent Newman in a growth phase dependent manner
from the exponential towards the stationary phase and
declined thereafter (Figure 3A). The course of luciferase
activity in the ΔyabJ-spoVG mutant SM148 and in the
ΔrsbUVW-sigB mutant IK184 was comparable but the
overall activity was reduced by a factor of two in
SM148, whereas it was two up to four times higher in
IK184. These effects were also mirrored by the intensity
of the esxA specific transcripts (Figure 3B). Since esxA
transcription in strain MS64 [24], a mutant with a stop
in sigB inactivating sB, was indistinguishable from that
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Figure 2 sA-dependence of the esxA promoter. Luciferase
activities of plasmids pesxAp-luc+ (wt), pesxApΔsA-luc+ (ΔsA) and
pesxApΔsB-luc+ (ΔsB) in S. aureus Newman. The strains were grown
in LB broth at 37°C and 180 rpm for 3 h. Data shown are the
means ± SD of four independent experiments. Statistical
significances between the different strains were assessed with a
paired, two-tailed Student’s t-test (* p < 0.01).
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in IK184, we could assign the upregulation of esxA tran-
scription to the loss of sB and exclude any contributions
of rsbUVW (data not shown).
To determine if either yabJ or spoVG inactivation was
responsible for the reduction of esxA transcription, we
complemented Newman, SM148 and IK184 in trans
with a series of plasmids expressing constitutively either
yabJ (pyabJ), spoVG (pspoVG), or yabJ-spoVG
(pyabJspoVG), circumventing the requirement of sB to
transcribe the yabJ-spoVG operon. Northern blot analy-
sis revealed that the constructs containing spoVG or
yabJ-spoVG, but not the one carrying yabJ, did restore
the esxA transcription to wild type level in SM148 (Fig-
ure 3C). In IK184, showing stronger esxA transcription
signals than the wild type, the esxA transcription was
even further enhanced by the complementation with
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Figure 3 Effect of sB and sB-controlled SpoVG on esxA expression. A. Transcriptional activity of the esxA promoter in strain Newman
(squares), SM148 (triangles), and IK184 (diamonds). Growth was followed by measuring the optical density at 600 nm [OD600] (open signs), and
the activity of the esxA promoter was determined by the luciferase activity of pesxAp-luc+ (filled signs). B. Northern blot analysis of esxA
transcription in Newman, the ΔyabJ-spoVG mutant (SM148) and the ΔrsbUVW-sigB mutant (IK184) over growth. C. Northern blot showing esxA
transcription in Newman, the ΔyabJ-spoVG mutant (SM148) and the ΔrsbUVW-sigB mutant (IK184) complemented with pBus1, pyabJ, pspoVG or
pyabJspoVG after 5 h of growth. Ethidium bromide-stained 16S rRNA patterns are shown as an indication of RNA loading.
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pspoVG or pyabJspoVG, confirming that SpoVG, but not
YabJ, had a positive effect on esxA expression in pre-
sence and absence of sB. However, the fact that esxA
transcription was strongly induced in IK184 lacking not
only sB, but consequently also the sB-dependent
SpoVG, suggested that esxA transcription may be acti-
vated by SpoVG but repressed by other sB-dependent
factors.
Influence of major regulators SarA, RNAIII and ArlR on
esxA
As sB and SpoVG had opposite effects on esxA expres-
sion, we searched for further sB-dependent regulators
that might be involved in esxA control, namely the two
major regulators of S. aureus, the agr system with its
effector molecule RNAIII; and the transcriptional regu-
lator SarA. A further candidate was ArlR, the response
regulator of the ArlRS two-component system, reported
to be activated by sB in strain Newman, and promoting
together with SpoVG capsule formation [9]. The tran-
script intensity of esxA in Newman compared to that in
its isogenic ΔsarA (LR15), Δagr (KS186) and ΔarlR
(SM99) mutants during growth, revealed a strong
upregulation of esxA in LR15, a downregulation in
KS186 and an even stronger attenuation in SM99 (Fig-
ure 4A), suggesting that SarA acts as repressor, and
RNAIII and ArlR as activators of esxA transcription.
This was confirmed by the level of luciferase activity of
pesxAp-luc+ during growth, which was highly increased
in the ΔsarA mutant (BS309), and lower in the Δagr
(BS310) and almost absent in ΔarlR (SM99) mutants
compared to the wild type Newman (Figure 4B). Inter-
estingly, as in capsule synthesis, SpoVG and ArlR acted
as elements enhancing the esxA expression [9].
Influence of EsxA on regulatory elements and itself
EsxA itself had no influence on the signal intensity or
activity of any of the above regulatory genes, neither on
asp23, as an indicator of sB activity [37,44,50], nor on
spoVG, arlR, sarA or RNAIII, when comparing their
expression in strain Newman and in the ΔesxA mutant
BS304 during the growth cycle (Additional file 1). We
could also rule out any autoregulatory effects of EsxA
on its own transcription, since luciferase activity pat-
terns of pesxAp-luc+ were congruent over the entire
growth cycle in Newman and BS304 (data not shown).
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Figure 4 Effect of SarA, agr and ArlR on esxA expression. A. Northern blot of esxA in Newman, and the ΔsarA (LR15), Δagr (KS186) and ΔarlR
(SM99) mutants over growth. The ethidium bromide-stained 16S rRNA pattern is shown as an indication of RNA loading. B. Transcriptional
activity of the esxA promoter in strain Newman (squares), ΔsarA mutant BS309 (stars/dots), Δagr mutant BS310 (triangles), and ΔarlR mutant SM99
(diamonds). Growth was followed by measuring the OD600 (open signs), and the activity of the esxA promoter-reporter construct was
determined by the luciferase activity of pesxAp-luc+ (filled signs). The strains BS309 and BS310 are isogenic to LR15 and KS186, respectively,
except for an exchanged resistance marker in the inactivated loci allowing the selection and maintenance of pesxAp-luc+ .
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Influence of SarA, RNAIII, sB, ArlR and SpoVG
on each other
An overview of the regulatory network influencing esxA
transcription is given in Figure 5, including also the
mutual interactions of the different regulators: sB activ-
ity was found to be comparable in all strains tested,
excluding secondary effects on esxA transcription due to
an altered sB activity (Additional file 2). We confirmed
the previously reported positive influence of sB on arlRS
and yabJspoVG transcription [7,9], as well as on sarA
transcription [3,7]. In contrast, we could not detect any
major changes in RNAIII transcript intensity in sB
mutants, although some studies suggest that sB activity
is reducing the RNAIII level [3,4] (Additional file 2).
Further, minor changes in transcription were observed
in the ΔsarA mutant where RNAIII was downregulated
and arlR transcripts were slightly upregulated, and in
the ΔarlR mutant where sarA transcription was
increased (Additional file 2: Figure S2A). However, these
dependencies could not explain the changes in esxA
transcription in the corresponding mutants.
Phenotypic characteristics of the ΔesxA mutant
The successful deletion of esxA reported here, and the
superimposable growth rates of wild type and esxA
mutant in complex LB medium, confirmed that EsxA
was not essential for growth in vitro (data not shown).
The growth defects observed in sigB and arlR mutants,
the former affecting late [37] and the latter reducing
early growth stages [19], can therefore also not depend
on altered EsxA expression. Although sB and SpoVG
are known to influence extracellular proteolytic activities
[9], and sB is known to repress hemolytic activity in S.
aureus [4,7,37], EsxA did neither affect proteolytic nor
hemolytic activities in BS304 (data not shown). As the
activity of the sigma factor sB and the sB-controlled
SpoVG positively influences methicillin and glycopeptide
resistance in methicillin resistant S. aureus (MRSA) and
in glycopeptide intermediate resistant S. aureus (GISA)
[8,51-55], we deleted esxA in MRSA strain BB1002 [26]
and GISA strain NM143 [27]. However, resistance levels
of the ΔesxA mutants BS307 and BS308 to oxacillin and
teicoplanin, respectively, were identical to those of the
parent strains, when measured by Etest (Table 3), as
well as by antibiotic gradient plates, which allow the
detection of very small differences in resistance (data
not shown). These results suggest that EsxA, which
enhances abscess formation in mice and is thought to
act either as transport chaperone or adaptor protein
[18], primarily plays a role as extracellular virulence fac-
tor in pathogenesis.
Conclusion
Our data suggest that the repression of esxA by sB is
due the sB-induced transcription of sarA, leading to a
strong and dominating SarA-mediated repression of
esxA. The activation of esxA transcription, on the other
hand, is stimulated by the agr quorum sensing system,
SarA SpoVGArlR
ıB
RNAIII
Environmental
and host factors
agr quorum
sensing system
esxA
virulence
Figure 5 Transcriptional regulation of esxA by global regulators of virulence in strain Newman. Major upregulation is represented by
green arrows, downregulation by red bars. Dashed lines indicate minor influences.
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the response regulator ArlR, and the effector protein
SpoVG; whereby arlR is controlled indirectly, and
spoVG directly by sB. Thereby the activating effect of
ArlR seems to be more profound than the effect of
SpoVG and agr. Moreover, virulence gene regulation in
S. aureus is very complex and additional factors might
contribute to the regulation of esxA transcription.
The mode of function of SpoVG, named after the stage
V sporulation protein G in Bacillus subtilis [7], and
SpoVG homologues in other bacterial species is yet
unknown, nor have any SpoVG interacting partners been
reported. SpoVG does not affect sB activity as seen from
the expression of asp23, which is a measure of sB activity
in S. aureus. SpoVG does also not interfere with the tran-
scription of sarA, arlRS nor agr in strain Newman.
By which mechanisms SpoVG counteracts the postu-
lated SarA-mediated repression of esxA remains open.
The affinity of SarA binding to DNA can be enhanced by
phosphorylation [56], but a postulated interaction of
SpoVG with SarA or other proteins has yet to be investi-
gated. Interestingly, the same stimulating effect by ArlRS
and SpoVG is seen in S. aureus capsule synthesis [9]. We
therefore can not rule out that SpoVG and ArlR may
interact or have some common target. SpoVG by itself
seems also to enhance transcription of esxA when artifi-
cially overexpressed in a sigB mutant. The absence of pre-
dicted DNA binding motifs in SpoVG may not fully
exclude its interaction with nucleic acids or with factors
involved in transcription. In conclusion, we have presented
here SpoVG, an interesting new player in the regulatory
cascade modulating S. aureus virulence factors.
Additional material
Additional file 1: No influence of EsxA on asp23, arlR, sarA, spoVG
and RNAIII transcription. Northern blot analysis comparing the
transcript intensities of asp23, arlR, sarA, spoVG and RNAIII in S. aureus
Newman and its ΔesxA mutant.
Additional file 2: Influence of SarA, RNAIII, sB, ArlR and SpoVG on
each other. Northern blot analysis comparing the transcript intensities of
asp23, arlR, sarA, spoVG and RNAIII in S. aureus Newman, and its isogenic
ΔsarA, Δagr, ΔarlR, ΔyabJspoVG and ΔrsbUVW-sigB mutant, respectively.
Acknowledgements
This study was carried out with financial support from the Forschungskredit
of the University of Zurich to BS, and from the Swiss National Science
Foundation grant 31-117707 to BBB.
Author details
1Institute of Medical Microbiology, University of Zurich, Gloriastrasse 32, 8006
Zurich, Switzerland. 2Cellular and Molecular Microbiology Division,
Interfaculty Institute of Microbiology and Infection Medicine, University of
Tübingen, Elfriede-Aulhorn-Strasse 6, 72076 Tübingen, Germany.
Authors’ contributions
BS carried out most of the experiments, participated in the design of the
study and drafted the manuscript. DAB participated in the transcriptional
analysis. BBB conceived the study, and participated in its design and
coordination, and helped to draft the manuscript. All authors read and
approved the final manuscript.
Received: 28 August 2011 Accepted: 24 January 2012
Published: 24 January 2012
References
1. Novick RP, Geisinger E: Quorum sensing in staphylococci. Annu Rev Genet
2008, 42:541-564.
2. Chien Y, Cheung AL: Molecular interactions between two global
regulators, sar and agr, in Staphylococcus aureus. J Biol Chem 1998,
273(5):2645-2652.
3. Bischoff M, Entenza JM, Giachino P: Influence of a functional sigB operon
on the global regulators sar and agr in Staphylococcus aureus. J Bacteriol
2001, 183(17):5171-5179.
4. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ: σB
modulates virulence determinant expression and stress resistance:
characterization of a functional rsbU strain derived from Staphylococcus
aureus 8325-4. J Bacteriol 2002, 184(19):5457-5467.
5. Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, Yang SJ,
Rice KC, Bayles KW, Smeltzer MS: Transcriptional profiling of a
Staphylococcus aureus clinical isolate and its isogenic agr and sarA
mutants reveals global differences in comparison to the laboratory
strain RN6390. Microbiology 2006, 152(Pt 10):3075-3090.
6. Ziebandt AK, Weber H, Rudolph J, Schmid R, Hoper D, Engelmann S,
Hecker M: Extracellular proteins of Staphylococcus aureus and the role of
SarA and σB. Proteomics 2001, 1(4):480-493.
7. Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W,
Berger-Bächi B, Projan S: Microarray-based analysis of the Staphylococcus
aureus σB regulon. J Bacteriol 2004, 186(13):4085-4099.
8. Schulthess B, Meier S, Homerova D, Goerke C, Wolz C, Kormanec J, Berger-
Bächi B, Bischoff M: Functional characterization of the σB-dependent
yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and
glycopeptide resistance. Antimicrob Agents Chemother 2009,
53(5):1832-1839.
9. Meier S, Goerke C, Wolz C, Seidl K, Homerova D, Schulthess B, Kormanec J,
Berger-Bächi B, Bischoff M: σB and the σB-dependent arlRS and yabJ-
spoVG loci affect capsule formation in Staphylococcus aureus. Infect
Immun 2007, 75(9):4562-4571.
10. Schulthess B, Bloes DA, Francois P, Girard M, Schrenzel J, Bischoff M, Berger-
Bächi B: σB-dependent yabJ-spoVG operon involved in the regulation of
extracellular nuclease, lipase and protease expression in Staphylococcus
aureus. J Bacteriol 2011, 193(18):4954-62.
11. Sibbald MJ, Ziebandt AK, Engelmann S, Hecker M, de Jong A, Harmsen HJ,
Raangs GC, Stokroos I, Arends JP, Dubois JY, et al: Mapping the pathways
to staphylococcal pathogenesis by comparative secretomics. Microbiol
Mol Biol Rev 2006, 70(3):755-788.
12. Siboo IR, Chaffin DO, Rubens CE, Sullam PM: Characterization of the
accessory Sec system of Staphylococcus aureus. J Bacteriol 2008,
190(18):6188-6196.
13. Biswas L, Biswas R, Nerz C, Ohlsen K, Schlag M, Schafer T, Lamkemeyer T,
Ziebandt AK, Hantke K, Rosenstein R, et al: Role of the twin-arginine
translocation pathway in Staphylococcus. J Bacteriol 2009,
191(19):5921-5929.
14. Burts ML, Williams WA, DeBord K, Missiakas DM: EsxA and EsxB are
secreted by an ESAT-6-like system that is required for the pathogenesis
Table 3 Oxacillin and teicoplanin MICs
Strain MIC (μg ml-1)
Oxacillin Teicoplanin
Newman 0.19 4
BS304 0.19 4
BB1002 > 256 3
BS307 > 256 3
NM143 0.25 12
BS308 0.25 12
Schulthess et al. BMC Microbiology 2012, 12:17
http://www.biomedcentral.com/1471-2180/12/17
Page 10 of 11
of Staphylococcus aureus infections. Proc Natl Acad Sci USA 2005,
102(4):1169-1174.
15. Anderson M, Chen Y-H, Butler EK, Missiakas DM: EsaD, a secretion factor
for the Ess pathway in Staphylococcus aureus. J Bacteriol 2011, JB.01096-
01010.
16. Pallen MJ: The ESAT-6/WXG100 superfamily and a new Gram-positive
secretion system? Trends Microbiol 2002, 10(5):209-212.
17. Burts ML, DeDent AC, Missiakas DM: EsaC substrate for the ESAT-6
secretion pathway and its role in persistent infections of Staphylococcus
aureus. Mol Microbiol 2008, 69(3):736-746.
18. Sundaramoorthy R, Fyfe PK, Hunter WN: Structure of Staphylococcus
aureus EsxA suggests a contribution to virulence by action as a
transport chaperone and/or adaptor protein. J Mol Biol 2008,
383(3):603-614.
19. Liang X, Zheng L, Landwehr C, Lunsford D, Holmes D, Ji Y: Global
regulation of gene expression by ArlRS, a two-component signal
transduction regulatory system of Staphylococcus aureus. J Bacteriol 2005,
187(15):5486-5492.
20. Fournier B, Klier A, Rapoport G: The two-component system ArlS-ArlR is a
regulator of virulence gene expression in Staphylococcus aureus.
Molecular Microbiology 2001, 41(1):247-261.
21. Duthie ES, Lorenz LL: Staphylococcal coagulase; mode of action and
antigenicity. J Gen Microbiol 1952, 6(1-2):95-107.
22. Adhikari RP, Novick RP: Regulatory organization of the staphylococcal sae
locus. Microbiology 2008, 154(3):949-959.
23. Kullik II, Giachino P: The alternative sigma factor σB in Staphylococcus
aureus: regulation of the sigB operon in response to growth phase and
heat shock. Arch Microbiol 1997, 167(2/3):151-159.
24. Senn MM, Giachino P, Homerova D, Steinhuber A, Strassner J, Kormanec J,
Fluckiger U, Berger-Bachi B, Bischoff M: Molecular analysis and
organization of the σB operon in Staphylococcus aureus. J Bacteriol 2005,
187(23):8006-8019.
25. Seidl K, Bischoff M, Berger-Bächi B: CcpA mediates the catabolite
repression of tst in Staphylococcus aureus. Infect Immun 2008,
76(11):5093-5099.
26. Vaudaux PE, Monzillo V, Francois P, Lew DP, Foster TJ, Berger-Bächi B:
Introduction of the mec element (methicillin resistance) into
Staphylococcus aureus alters in vitro functional activities of fibrinogen
and fibronectin adhesins. Antimicrob Agents Chemother 1998,
42(3):564-570.
27. Seidl K, Stucki M, Ruegg M, Goerke C, Wolz C, Harris L, Berger-Bächi B,
Bischoff M: Staphylococcus aureus CcpA affects virulence determinant
production and antibiotic resistance. Antimicrob Agents Chemother 2006,
50(4):1183-1194.
28. Bae T, Schneewind O: Allelic replacement in Staphylococcus aureus with
inducible counter-selection. Plasmid 2006, 55(1):58-63.
29. Rezuchova B, Miticka H, Homerova D, Roberts M, Kormanec J: New
members of the Escherichia coli σE regulon identified by a two-plasmid
system. FEMS Microbiol Lett 2003, 225(1):1-7.
30. Homerova D, Bischoff M, Dumolin A, Kormanec J: Optimization of a two-
plasmid system for the identification of promoters recognized by RNA
polymerase containing Staphylococcus aureus alternative sigma factor
σB. FEMS Microbiol Lett 2004, 232(2):173-179.
31. Rossi J, Bischoff M, Wada A, Berger-Bächi B: MsrR, a putative cell envelope-
associated element involved in Staphylococcus aureus sarA attenuation.
Antimicrob Agents Chemother 2003, 47(8):2558-2564.
32. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA,
Struhl K: Current protocols in molecular biology New York, NY: John Wiley &
Sons, Inc; 1987.
33. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual
Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
34. Wada A, Katayama Y, Hiramatsu K, Yokota T: Southern hybridization
analysis of the mecA deletion from methicillin-resistant Staphylococcus
aureus. Biochem Biophys Res Commun 1991, 176(3):1319-1325.
35. Chan PF, Foster SJ: Role of SarA in virulence determinant production and
environmental signal transduction in Staphylococcus aureus. J Bacteriol
1998, 180(23):6232-6241.
36. Seidl K, Goerke C, Wolz C, Mack D, Berger-Bächi B, Bischoff M:
Staphylococcus aureus CcpA affects biofilm formation. Infect Immun 2008,
76(5):2044-2050.
37. Giachino P, Engelmann S, Bischoff M: σB activity depends on RsbU in
Staphylococcus aureus. J Bacteriol 2001, 183(6):1843-1852.
38. McCallum N, Hinds J, Ender M, Berger-Bächi B, Stutzmann Meier P:
Transcriptional profiling of XdrA, a new regulator of spa transcription in
Staphylococcus aureus. J Bacteriol 2010, 192(19):5151-5164.
39. Cheung AL, Eberhardt KJ, Fischetti VA: A method to isolate RNA from
gram-positive bacteria and mycobacteria. Anal Biochem 1994,
222(2):511-514.
40. Goda SK, Minton NP: A simple procedure for gel electrophoresis and
northern blotting of RNA. Nucleic Acids Res 1995, 23(16):3357-3358.
41. McCallum N, Karauzum H, Getzmann R, Bischoff M, Majcherczyk P, Berger-
Bächi B, Landmann R: In vivo survival of teicoplanin-resistant
Staphylococcus aureus and fitness cost of teicoplanin resistance.
Antimicrob Agents Chemother 2006, 50(7):2352-2360.
42. McCallum N, Bischoff M, Maki H, Wada A, Berger-Bächi B: TcaR, a putative
MarR-like regulator of sarS expression. J Bacteriol 2004, 186(10):2966-2972.
43. Wang L, Trawick JD, Yamamoto R, Zamudio C: Genome-wide operon
prediction in Staphylococcus aureus. Nucleic Acids Res 2004,
32(12):3689-3702.
44. Kullik I, Giachino P, Fuchs T: Deletion of the alternative sigma factor σB in
Staphylococcus aureus reveals its function as a global regulator of
virulence genes. J Bacteriol 1998, 180(18):4814-4820.
45. Nicholas RO, Li T, McDevitt D, Marra A, Sucoloski S, Demarsh PL, Gentry DR:
Isolation and characterization of a sigB deletion mutant of
Staphylococcus aureus. Infect Immun 1999, 67(7):3667-3669.
46. Deora R, Misra TK: Characterization of the primary sigma factor of
Staphylococcus aureus. J Biol Chem 1996, 271(36):21828-21834.
47. Rao L, Karls RK, Betley MJ: In vitro transcription of pathogenesis-related
genes by purified RNA polymerase from Staphylococcus aureus.
J Bacteriol 1995, 177(10):2609-2614.
48. Shine J, Dalgarno L: The 3’-terminal sequence of Escherichia coli 16S
ribosomal RNA: complementarity to nonsense triplets and ribosome
binding sites. Proc Natl Acad Sci USA 1974, 71(4):1342-1346.
49. Zuker M: Mfold web server for nucleic acid folding and hybridization
prediction. Nucleic Acids Res 2003, 31(13):3406-3415.
50. Gertz S, Engelmann S, Schmid R, Ohlsen K, Hacker J, Hecker M: Regulation
of σB-dependent transcription of sigB and asp23 in two different
Staphylococcus aureus strains. Mol Gen Genet 1999, 261(3):558-566.
51. Bischoff M, Berger-Bächi B: Teicoplanin stress-selected mutations
increasing σB activity in Staphylococcus aureus. Antimicrob Agents
Chemother 2001, 45(6):1714-1720.
52. Singh VK, Schmidt JL, Jayaswal RK, Wilkinson BJ: Impact of sigB mutation
on Staphylococcus aureus oxacillin and vancomycin resistance varies
with parental background and method of assessment. Int J Antimicrob
Agents 2003, 21(3):256-261.
53. Price CT, Singh VK, Jayaswal RK, Wilkinson BJ, Gustafson JE: Pine oil
cleaner-resistant Staphylococcus aureus: reduced susceptibility to
vancomycin and oxacillin and involvement of σB. Appl Environ Microbiol
2002, 68(11):5417-5421.
54. Morikawa K, Maruyama A, Inose Y, Higashide M, Hayashi H, Ohta T:
Overexpression of sigma factor, σB, urges Staphylococcus aureus to
thicken the cell wall and to resist beta-lactams. Biochem Biophys Res
Commun 2001, 288(2):385-389.
55. Wu S, de Lencastre H, Tomasz A: Sigma-B, a putative operon encoding
alternate sigma factor of Staphylococcus aureus RNA polymerase:
molecular cloning and DNA sequencing. J Bacteriol 1996,
178(20):6036-6042.
56. Didier JP, Cozzone AJ, Duclos B: Phosphorylation of the virulence
regulator SarA modulates its ability to bind DNA in Staphylococcus
aureus. FEMS Microbiol Lett 2010, 306(1):30-36.
doi:10.1186/1471-2180-12-17
Cite this article as: Schulthess et al.: Opposing roles of sB and sB-
controlled SpoVG in the global regulation of esxA in
Staphylococcus aureus. BMC Microbiology 2012 12:17.
Schulthess et al. BMC Microbiology 2012, 12:17
http://www.biomedcentral.com/1471-2180/12/17
Page 11 of 11
